Pat is a managing director with Deloitte Risk & Financial Advisory for Deloitte & Touche LLP and has more than 15 years of experience in regulatory compliance concerning the manufacturing and distribution of both pharmaceutical and medical device products. He focuses on providing life sciences companies with strategic guidance and management in the areas of compliance and regulatory affairs.
Pat works with clients in the areas of risk assessments, policies and procedures, IT validation, compliance with Title 21 Code of Federal Regulations (CFR) Part 11, and risk-based approaches to regulatory compliance management. He has provided high-level consulting guidance to many Fortune 500 pharmaceutical, medical device, and biotech companies, including the top 15 pharmaceutical companies globally.
